3 completed, 1 withdrawn. 4 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Withdrawn 1 |
| Phase 1 | 3 | Completed 2, Withdrawn 1 |
Follow VM202: new trials by email Literature Review of VM202 trials Research Report on VM202
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hepatocyte Growth Factor to Improve Functioning in PAD VM202, Placebo - Peripheral Artery Disease | Phase 2 | Completed | Northwestern University | 39 | 2018-01-01 | 2024-05-30 |
| Gene Therapy for the Treatment of Chronic Stable Angina VM202 - Myocardial Ischemia | Phase 1 / Phase 2 | Withdrawn | Helixmith Co., Ltd. | 2015-03-01 | 2025-09-25 | |
| Safety Study of VM202 to Treat Amyotrophic Lateral Sclerosis VM202 - Amyotrophic Lateral Sclerosis | Phase 1 / Phase 2 | Completed | Helixmith Co., Ltd. | 18 | 2014-03-11 | 2025-10-06 |
| Gene Therapy for Painful Diabetic Neuropathy VM202 - Painful Diabetic Peripheral Neuropathy | Phase 1 / Phase 2 | Completed | Helixmith Co., Ltd. | 12 | 2010-02-01 | 2025-10-06 |
Amyotrophic Lateral Sclerosis (1) · Angina Pectoris (1) · Coronary Disease (1) · Diabetes Mellitus (1) · Ischemia (1) · Myocardial Ischemia (1) · Neurodegenerative Diseases (1) · Peripheral Arterial Disease (1)
Helixmith Co., Ltd. (3) · Northwestern University (1)
United States (4)
John A Kessler, MD (1) · John Kessler, M.D. (1) · Mary McDermott, MD (1)
R21AG056903 (1)